Andreoli, Michael T., Michael Pinnolis, Troy Kieser, Jennifer Sun, and Christopher M. Andreoli. “Feasibility and Efficacy of a Mass Switch from Ranibizumab (Lucentis) to Bevacizumab (Avastin) for Treatment of Neovascular Age-Related Macular Degeneration”. Digital Journal of Ophthalmology 21, no. 3 (September 11, 2015): 29–34. Accessed May 1, 2026. https://djo.harvard.edu/index.php/djo/article/view/380.